Neuronetics
PATIENTS   PHYSICIANS   PRODUCTS   CLINICAL TRIALS  ABOUT US  CONTACT HOME    

Transcranial Magnetic Stimulation (TMS) Therapy involves the use of MRI-strength magnetic fields to stimulate nerve cells in the brain. First used in 1985, TMS has been utilized by researchers around the world to help understand the function of parts of the brain.
Learn more.

The short pulses of magnetic energy produced by a TMS device are aimed by the treating clinician at the structures in the brain involved in mood regulation. Watch the video on How TMS Therapy Works.

Read what people are saying about us. For the latest news on Neuronetics and NeuroStar TMS Therapy, click here.

Read the Newsweek article on repetitive transcranial magnetic stimulation (rTMS): "Minds and Magnets"

New Hope for patients with major depressive disorder
NeuroStar TMS Therapy

A new, non-invasive
treatment option

NeuroStar TMS Therapy is a non-invasive, 40-minute outpatient procedure that does not require sedation or anesthesia. Clinical trials have studied its efficacy and safety in treating depressed patient who have had an inadequate response to previous therapies. Read more.

To view NeuroStar TMS Therapy clinical data presentations,
click here.

Despite advances in treatment, major depression remains a serious problem.

Major depression is a common and serious medical illness affecting more than 13 million Americans, or approximately 6.6 percent of the population in a given year. Read more.

Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial

This study was recently published in the December 2007 issue of Biological Psychiatry. To read the article abstract or obtain a full text copy, click here. To view the press release written and issued by the peer-reviewed psychiatry journal, Biological Psychiatry, click here.

Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction Treatment

This article was recently published in the February 2008 issue of The Journal of Clinical Psychiatry. To read the article abstract or obtain a full text copy, click here. To view the press release, click here.

Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial

This study was recently published in the March 2008 issue of The Journal of Clinical Psychiatry. To read the article abstract or obtain a full text copy, click here.

New Data Analysis Identifies Depressed Patients Who are Most Likely to Benefit From Treatment with NeuroStar TMS Therapy

Data further suggests that NeuroStar TMS Therapy compares favorably to antidepressant medications. To view the press release, click here.

Caution: Investigational device. Limited by federal law to investigational use.

PRIVACY POLICY

COPYRIGHT NEURONETICS 2006-2007

ALL RIGHTS RESERVED

52-50002-000

Rev Q